Founders Capital Management (Texas)’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.54K | Hold |
500
| – | – | ﹤0.01% | 321 |
|
|
2025
Q1 | $4.77K | Hold |
500
| – | – | ﹤0.01% | 308 |
|
|
2024
Q4 | $5.62K | Hold |
500
| – | – | ﹤0.01% | 302 |
|
|
2024
Q3 | $7.19K | Hold |
500
| – | – | ﹤0.01% | 304 |
|
|
2024
Q2 | $8.63K | Hold |
500
| – | – | 0.01% | 288 |
|
|
2024
Q1 | $9.97K | Hold |
500
| – | – | 0.01% | 288 |
|
|
2023
Q4 | $5.26K | Hold |
500
| – | – | ﹤0.01% | 328 |
|
|
2023
Q3 | $4.42K | Hold |
500
| – | – | ﹤0.01% | 348 |
|
|
2023
Q2 | $4.82K | Hold |
500
| – | – | ﹤0.01% | 344 |
|
|
2023
Q1 | $7K | Sell |
500
-500
| -50% | -$7K | 0.01% | 336 |
|
|
2022
Q4 | $15K | Hold |
1,000
| – | – | 0.01% | 262 |
|
|
2022
Q3 | $9K | Hold |
1,000
| – | – | 0.01% | 304 |
|
|
2022
Q2 | $8K | Buy |
+1,000
| New | +$8K | 0.01% | 338 |
|